A detailed history of State Of Wisconsin Investment Board transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 203,470 shares of CPRX stock, worth $3.97 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
203,470
Previous 235,963 13.77%
Holding current value
$3.97 Million
Previous $3.66 Million 10.64%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.19 - $21.35 $493,568 - $693,725
-32,493 Reduced 13.77%
203,470 $4.04 Million
Q2 2024

Aug 14, 2024

BUY
$14.68 - $16.92 $375,235 - $432,492
25,561 Added 12.15%
235,963 $3.66 Million
Q1 2024

May 14, 2024

BUY
$13.18 - $17.11 $756,149 - $981,617
57,371 Added 37.49%
210,402 $3.35 Million
Q4 2023

Feb 12, 2024

BUY
$11.78 - $17.29 $803,431 - $1.18 Million
68,203 Added 80.4%
153,031 $2.57 Million
Q3 2023

Nov 14, 2023

SELL
$11.69 - $15.02 $21,579 - $27,726
-1,846 Reduced 2.13%
84,828 $991,000
Q2 2023

Aug 14, 2023

SELL
$11.5 - $18.08 $52,060 - $81,848
-4,527 Reduced 4.96%
86,674 $1.16 Million
Q1 2023

May 15, 2023

SELL
$14.34 - $21.05 $97,210 - $142,697
-6,779 Reduced 6.92%
91,201 $1.51 Million
Q4 2022

Feb 14, 2023

SELL
$12.25 - $19.5 $18,620 - $29,640
-1,520 Reduced 1.53%
97,980 $1.82 Million
Q3 2022

Nov 14, 2022

SELL
$7.06 - $15.52 $38,335 - $84,273
-5,430 Reduced 5.17%
99,500 $1.28 Million
Q2 2022

Aug 15, 2022

SELL
$6.23 - $8.57 $171,138 - $235,417
-27,470 Reduced 20.75%
104,930 $736,000
Q1 2022

May 13, 2022

SELL
$5.31 - $8.31 $208,682 - $326,583
-39,300 Reduced 22.89%
132,400 $1.1 Million
Q4 2021

Feb 11, 2022

BUY
$5.21 - $7.45 $204,753 - $292,785
39,300 Added 29.68%
171,700 $1.16 Million
Q4 2020

Feb 03, 2021

SELL
$2.97 - $3.83 $49,005 - $63,195
-16,500 Reduced 11.08%
132,400 $442,000
Q1 2020

May 06, 2020

BUY
$2.61 - $5.21 $10,962 - $21,882
4,200 Added 2.9%
148,900 $573,000
Q3 2019

Nov 12, 2019

BUY
$3.89 - $7.43 $52,515 - $100,305
13,500 Added 10.29%
144,700 $768,000
Q2 2019

Aug 14, 2019

BUY
$2.7 - $6.11 $7,830 - $17,719
2,900 Added 2.26%
131,200 $504,000
Q1 2019

May 13, 2019

BUY
$2.11 - $5.33 $61,822 - $156,169
29,300 Added 29.6%
128,300 $654,000
Q4 2018

Feb 11, 2019

BUY
$1.92 - $3.62 $86,400 - $162,900
45,000 Added 83.33%
99,000 $190,000
Q3 2017

Nov 01, 2017

BUY
$2.4 - $2.94 $129,600 - $158,760
54,000
54,000 $136,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.01B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.